fda declaratory order semaglutide shortage resolved february 21 2025 says Wegovy and Ozempic resolved; Hims & Hers stock falls FDA declares end to Wegovy

This specificity is believed to contribute to its lower risk of side effects and its effectiveness in treating mood disorders

Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices

They help curb appetite, slow gastric emptying, and reduce postprandial glucose spikes. Youve likely encountered names such as semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda). Early versions of these drugs required daily injection

TRIUMPH-1: Retatrutide Isn't Replacing Zepbound